A 7509 (see companion bill S 4788A) – New York
Introduced: 2018 Status: Enacted
INTERCHANGEABLE BIOLOGICAL PRODUCTS: Allows a pharmacist to dispense a lower cost generically equivalent drug product or interchangeable biological product.
A 8824 (see companion bill S 398) – New York
Introduced: 2022 Status: In Process
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
A 8838 (see companion bill S 7837) – New York
Introduced: 2022 Status: In Process
Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy …
AB 1046 (see companion bill SB 874) – Wisconsin
Introduced: 2018 Status: Inactive / Dead
This bills requires that no manufacturer or wholesale distributor may sell or offer to sell an essential off-patent or generic drug at a price that results in price gouging. Under the bill, price gouging means …
AB 1064 – California
Introduced: 2021 Status: Enacted
Pharmacy practice: vaccines: independent initiation and administration. Existing law, the Pharmacy Law, establishes the California State Board of Pharmacy within the Department of Consumer Affairs and sets forth its powers and duties relating to the …
AB 114 (see companion bill SB 100) – Wisconsin
Introduced: 2019 Status: Inactive / Dead
Registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. The bill requires pharmacy benefit managers to provide a reasonably adequate and accessible network of pharmacies. The bill …
AB 265 – California
Introduced: 2017 Status: Enacted
Prescription drugs: prohibition on price discount: This bill would generally prohibit a person who manufactures a prescription drug from offering in California any discount, repayment, product voucher, or other reduction in an individual’s out-of-pocket expenses …
AB 679 (see companion bill SB 575) – Wisconsin
Introduced: 2017 Status: Inactive / Dead
A pharmacist shall dispense every prescription using either the biological product prescribed or an interchangeable biological product, if the interchangeable biological product is lower in price to the consumer than the biological product prescribed, and …
AB 824 – California
Introduced: 2019 Status: Enacted
Business: preserving access to affordable drugs – This bill would provide that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical …
AR 184 – New Jersey
Introduced: 2017 Status: Inactive / Dead
URGES FDA TO EXPEDITE APPROVAL PROCESS FOR GENERIC DRUGS: To expedite access to generic drugs, for the next 47 reauthorization of the Generic Drug User Fee Act (GDUFA), the FDA should consider additional steps to …
Ariz. Rev. Stat. § 32-1963.01. Substitution for prescription drugs or biological products; requirements; label; definitions: Pharmacy — Regulation – Arizona
Status: Enacted Year Enacted: 2000
Allows pharmacists to substitute generics. Must disclose price difference to consumer if they choose not to substitute.
Download
Ariz. Rev. Stat. §§ 44-1751 through 44-1754: Regulations Concerning Particular Businesses — Pharmacy Benefit Managers – Arizona
Status: Enacted Year Enacted: 2018
Provides regulation of pharmacy benefit managers, such as they may not prohibit a pharmacist or pharmacy from providing an insured individual information on the amount of the insured’s cost share for the insured’s prescription drug …
Download
Cal. Bus. & Prof. Code §§ 4050 through 4068: Pharmacy — Scope of Practice and Exemptions – California
Status: Enacted Year Enacted: 1996
Notwithstanding any other law, a pharmacist may authorize the initiation of a prescription, pursuant to Section 4052.1, 4052.2, 4052.3, or 4052.6, and otherwise provide clinical advice, services, information, or patient consultation, as set forth in …
Download
Colo. Rev. Stat. §§ 25.5-2.5-101 through 25.5-2.5-103: Colorado Cares Rx Act – Colorado
Status: Enacted Year Enacted: 2007
The State shall make information regarding prescription drugs available to the public, including but not limited to, ways in which the uninsured can access lower cost prescription drugs and contact information for lower cost programs.
Download
Conn. Gen. Stat. § 20-14a. Prescription of drugs by generic name. Disclosure to patient. Labeling: Medicine and Surgery – Connecticut
Status: Enacted Year Enacted: 1972
For the purposes of this section, “brand name” means the name the manufacturer places upon a drug or pharmaceutical or on its container, label, or wrapping at the time of packaging; and “generic name” means …
Download
D.C. Code § 31-3834.03. Coverage of additional preventive health services: Women’s Rights Regarding Certain Health Insurance – District of Columbia
Status: Enacted Year Enacted: 2001
Health insurance coverage through Medicaid or the D.C. Healthcare Alliance program shall also provide additional coverage and shall not impose any cost-sharing requirements for these additional benefits.
Download